Public Employees Retirement System of Ohio Takes $4.13 Million Position in Solventum Corporation $SOLV

Public Employees Retirement System of Ohio bought a new stake in Solventum Corporation (NYSE:SOLV) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 53,551 shares of the company’s stock, valued at approximately $4,131,000.

Other institutional investors have also recently bought and sold shares of the company. BOKF NA lifted its position in shares of Solventum by 6.9% in the third quarter. BOKF NA now owns 2,193 shares of the company’s stock valued at $160,000 after buying an additional 141 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in Solventum by 23.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 744 shares of the company’s stock valued at $60,000 after purchasing an additional 142 shares during the last quarter. NewEdge Advisors LLC boosted its position in Solventum by 2.2% during the first quarter. NewEdge Advisors LLC now owns 6,707 shares of the company’s stock worth $438,000 after purchasing an additional 144 shares during the period. Deseret Mutual Benefit Administrators boosted its position in Solventum by 39.5% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 516 shares of the company’s stock worth $41,000 after purchasing an additional 146 shares during the period. Finally, HB Wealth Management LLC increased its holdings in shares of Solventum by 3.5% in the first quarter. HB Wealth Management LLC now owns 4,292 shares of the company’s stock valued at $280,000 after purchasing an additional 147 shares during the last quarter.

Solventum Trading Up 0.6%

SOLV stock opened at $92.44 on Friday. Solventum Corporation has a 52 week low of $62.38 and a 52 week high of $94.16. The company has a market capitalization of $15.74 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61. The company’s 50-day simple moving average is $83.76 and its 200 day simple moving average is $75.90. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02.

Solventum (NYSE:SOLV) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.91 by $0.64. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.15 billion. During the same quarter in the previous year, the firm posted $1.69 EPS. The business’s revenue for the quarter was up 2.2% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, sell-side analysts anticipate that Solventum Corporation will post 7.22 earnings per share for the current year.

Analysts Set New Price Targets

SOLV has been the subject of a number of research reports. BMO Capital Markets began coverage on shares of Solventum in a research note on Wednesday, July 8th. They set a “market perform” rating and a $81.00 target price for the company. Piper Sandler upped their price target on shares of Solventum from $92.00 to $105.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. BTIG Research increased their price target on shares of Solventum from $91.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Mizuho set a $113.00 price objective on shares of Solventum in a research report on Thursday, August 6th. Finally, Weiss Ratings upgraded Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, August 18th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Solventum presently has a consensus rating of “Moderate Buy” and an average price target of $91.64.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.